David Woodhouse is the founder of NGM Biopharmaceuticals. has over 23 years of experience in the biopharmaceutical industry.
David J. Woodhouse, Ph.D. has over 23 years of experience in the biopharmaceutical industry, with expertise in scientific research, strategy, finance, and capital development. He currently serves as the Chief Executive Officer at Nuvig Therapeutics and as the Chairman of the Board at Surrozen Inc. Previously, he was Chief Executive Officer and CFO at NGM Biopharmaceuticals, and also worked as an investment banker at Goldman Sachs & Co. LLC.
Full founder directory · Investor directory · Company funding database · Fundraising library